| Literature DB >> 35164402 |
Khalid Chebbac1, Hazem K Ghneim2, Abdelfattah El Moussaoui3, Mohammed Bourhia4, Azeddin El Barnossi3, Zineb Benziane Ouaritini5, Ahmad Mohammad Salamatullah6, Abdulhakeem Alzahrani6, Mourad A M Aboul-Soud2, John P Giesy7,8,9,10, Raja Guemmouh1.
Abstract
This study investigated the chemical composition, antioxidant and antimicrobial activity of essential oil extracted from Artemisia aragonensis Lam. (EOA). Hydrodistillation was employed to extract EOA. Gas chromatography with flame ionization detection (GC-FID) and gas chromatography-mass spectrometry analyses (GC-MS) were used to determine the phytochemical composition of EOA. Antioxidant potential was examined in vitro by use of three tests: 2.2-diphenyl-1-picrilhidrazil (DPPH), ferric reducing activity power (FRAP) and total antioxidant capacity assay (TAC). Agar diffusion and microdilution bioassays were used to assess antimicrobial activity. GC/MS and GC-FID detected 34 constituents in the studied EOA. The major component was Camphor (24.97%) followed by Borneol (13.20%), 1,8 Cineol (10.88%), and Artemisia alcohol (10.20%). EOA exhibited significant antioxidant activity as measured by DPPH and FRAP assays, with IC50 and EC50 values of 0.034 ± 0.004 and 0.118 ± 0.008 mg/mL, respectively. EOA exhibited total antioxidant capacity of 7.299 ± 1.774 mg EAA/g. EOA exhibited potent antibacterial activity as judged by the low minimum inhibitory concentration (MIC) values against selected clinically-important pathogenic bacteria. MIC values of 6.568 ± 1.033, 5.971 ± 1.033, 7.164 ± 0.0 and 5.375 ± 0.0 μg/mL were observed against S. aureus, B. subtills, E. coli 97 and E. coli 57, respectively. EOA displayed significant antifungal activity against four strains of fungi: F. oxysporum, C. albicans, A. flavus and A. niger with values of 21.50 ± 0.43, 5.31 ± 0.10, 21.50 ± 0.46 and 5.30 ± 0.036 μg/mL, respectively. The results of the current study highlight the importance of EOA as an alternative source of natural antioxidant and antibacterial drugs to combat antibiotic-resistant microbes and free radicals implicated in the inflammatory responses accompanying microbial infection.Entities:
Keywords: antibacterial; antimicrobial resistance; antioxidant; essential oils; phytochemical analysis
Mesh:
Substances:
Year: 2022 PMID: 35164402 PMCID: PMC8840534 DOI: 10.3390/molecules27031136
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chromatographic profile of EOA profiled by GC-MS.
Phytochemical components identified in EOA by GC-MS.
| RI | ||||||
|---|---|---|---|---|---|---|
| Area (%) | Lit | Obs | Chemical Classes | Compound Name | R.T (min) | P |
| 1.53 | 933 | 933 | MO.H | α-Pinene | 7.84 | 1 |
| 3.1 | 949 | 948 | MO.H | Camphene | 8.23 | 2 |
| 1.43 | 980 | 982 | MO.H | β-Pinene | 9.17 | 3 |
| 2.75 | 999 | 998 | MO.O | Yamogi alcohol | 10.15 | 4 |
| 0.69 | 1026 | 1024 | MO.H | o-Cymene | 10.78 | 5 |
| 10.88 | 1032 | 1030 | MO.O | 1,8-Cineole | 11.03 | 6 |
| 0.48 | 1017 | 1019 | MO.H | α-Terpinene | 12.15 | 7 |
| 10.2 | 1083 | 1089 | MO.O | Artemisia alcohol | 13.11 | 8 |
| 0.51 | 1102 | 1107 | MO.O | Thujone | 13.39 | 9 |
| 24.97 | 1146 | 1151 | MO.O | Camphor | 14.57 | 10 |
| 0.52 | 1139 | 1145 | MO.O | Trans-pinocarveol | 14.65 | 11 |
| 0.44 | 1164 | 1163 | MO.O | Pinocarvone | 15.16 | 12 |
| 13.2 | 1169 | 1171 | MO.O | Borneol | 15.66 | 13 |
| 1.39 | 1082 | 1084 | MO.O | Terpinen-4-ol | 16.09 | 14 |
| 1 | 1173 | 1178 | O | Artemisia acetate | 16.24 | 15 |
| 0.69 | 1133 | 1137 | MO.O | α–Terpineol | 16.51 | 16 |
| 2.73 | 1198 | 1195 | MO.O | Myrtenol | 16.73 | 17 |
| 0.42 | 1216 | 1220 | MO.O | Trans-Carveol | 17.46 | 18 |
| 1.44 | 1237 | 1239 | MO.O | Pulegone | 17.87 | 19 |
| 2.33 | 1288 | 1286 | O | Bornyl acetate | 19.8 | 20 |
| 0.83 | 1326 | 1327 | O | Myrtenyl acetate | 21.05 | 21 |
| 0.75 | 1376 | 1372 | SQ.H | α-Copaene | 23.11 | 22 |
| 0.71 | 1485 | 1480 | SQ.H | Germacrene D | 26.12 | 23 |
| 1.26 | 1578 | 1579 | SQ.O | Spathulenol | 28.66 | 24 |
| 1.26 | 1586 | 1583 | SQ.O | Caryophyllene oxide | 28.77 | 25 |
| 0.5 | 1624 | 1625 | SQ.O | Isospathulenol | 30.12 | 26 |
| 2.2 | 1632 | 1633 | SQ.O | γ-Eudesmo | 30.26 | 27 |
| 0.51 | 1640 | 1642 | SQ.O | Cadinol | 30.5 | 28 |
| 1.3 | 1650 | 1652 | SQ.O | β-Eudesmo | 30.64 | 29 |
| 0.45 | 1658 | 1657 | SQ.O | Bisabolol oxyde B | 30.93 | 30 |
| 5.63 | 1685 | 1688 | SQ.O | Bisabolone oxide A | 31.45 | 31 |
| 0.56 | 1749 | 1751 | SQ.O | α-Bisabolol oxide A | 33.14 | 32 |
| 1.33 | 2800 | 2804 | O | Octacosane | 40.32 | 33 |
| 1.63 | 2500 | 2503 | ST.H | Pentacosane | 42.99 | 34 |
| Chemical classes | ||||||
| 7.23 | Monoterpene hydrocarbons (MO.H) | |||||
| 70.14 | Oxygenated monoterpenes (MO.O) | |||||
| 1.46 | Sesquiterpene hydrocarbons (SQ.H) | |||||
| 13.67 | Oxygenated sesquiterpenes (SQ.O) | |||||
| 1.63 | Sesterpene (ST.H) | |||||
| 5.49 | Other compounds (O) | |||||
| 99.62 | Total identification | |||||
P: Peak; R.T: Retention time; Obs: Observed; Lit: Literature; R.I: Retention index; MO.H: Monoterpene hydrocarbons; MO.O: Oxygenated monoterpenes; SQ.H: Sesquiterpene hydrocarbons; SQ.O: Oxygenated sesquiterpenes; ST.H: Sesterpene; O: Other compounds.
Figure 2Molecular structure of some major phytochemicals identified in EOA.
Figure 3(A) Anti-radical activity of EOA and controls (BHT, Ascorbic Acid and Qercetin) by use of DPPH assay. (B) IC50 values of anti-radical activity of EOA and controls (BHT, Ascorbic Acid and Qercetin).
Figure 4(A) Ferric reducing antioxidant power of EOA and controls (BHT, Ascorbic Acid and Qercetin). (B) IC50 values of Ferric reducing antioxidant power of EOA and controls (BHT, Ascorbic Acid and Qercetin).
Inhibition zones induced by EOA and controls (Streptomycin and Ampicillin) vs. bacterial strains (mm).
| Compound | Gram-Negative Bacteria | Gram-Positive Bacteria | ||
|---|---|---|---|---|
|
|
| |||
| Essential oil | 13.00 ± 0.00 a | 13.67 ± 1.15 a | 14.67 ± 0.58 a | 13.33 ± 0.58 a |
| Streptomycin | _ | _ | 9.11 ± 0.43 | _ |
| Ampicillin | _ | _ | _ | _ |
Row values with the same letter (a) did not differ significantly (means ± SD, n = 3, one-way ANOVA; Tukey’s test, p ≤ 0.05).
Minimum inhibitory concentration induced by EOA and controls (Streptomycin and Ampicillin) vs. bacterial strains (µg/mL).
| Compound | Gram-Negative Bacteria | Gram-Positive Bacteria | ||
|---|---|---|---|---|
|
|
| |||
| EOA | 5.375 ± 0.00 a | 5.971 ± 1.033 a | 6.568 ± 1.033 a | 7.164 ± 0.0 a |
| Streptomycin | 0.25 ± 0.00 a | 0.5 ± 0.00 b | 0.062 ± 0.00 c | _ |
| Ampicillin | _ | _ | _ | _ |
Row values with the same letters (a, b or c) did not differ significantly (means ± SD, n = 3, one-way ANOVA; Tukey’s test, p ≤ 0.05).
Figure 5Photographs displaying the effects of EOA on the tested bacteria.
Evaluation of the antifungal activity of EOA and Fluconazole by use of inhibition zone and minimum inhibitory concentration (MIC).
| Inhibition Diameter (mm) | Minimum Inhibitory Concentration (µg/mL) | |||
|---|---|---|---|---|
| Fungal Strains | EOA | Fluconazole | EOA | Fluconazole |
|
| 68.51 ± 1.06 a | 36.12 ± 3.70 b | 21.50 ± 0.43 c | 2.01 ± 0.01 d |
|
| 71.72 ± 0.52 a | 29.41 ± 5.07 b | 5.31 ± 0.10 c | 1.21 ± 0.01 d |
|
| 46.50 ± 1.01 a | 39.52 ± 2.16 a | 21.50 ± 0.46 a | 1.82 ± 0.01 d |
|
| 40.00 ± 1.0 a | 33.08 ± 4.17 a | 5.30 ± 0.036 c | 3.12 ± 0.20 d |
Row values with the same letters (a, b, c or d) did not differ significantly (means ± SD, n = 3, one-way ANOVA; Tukey’s test, p ≤ 0.05).
Figure 6Photographs displaying the effects of EOA on the tested fungi.